CORNIFIED ENVELOPE ASSOCIATED PROTEINS AND PERMEABILITY BARRIER FUNCTION
角化包膜相关蛋白和渗透性屏障功能
基本信息
- 批准号:6197172
- 负责人:
- 金额:$ 19.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-08-01 至 2000-07-31
- 项目状态:已结题
- 来源:
- 关键词:calcium binding protein calcium channel clinical research congenital ichthyosis epidermolysis bullosa essential fatty acids genetically modified animals human subject intermediate filaments keratin keratinocyte keratosis laboratory mouse membrane permeability membrane proteins membrane structure nutrition related tag protein glutamine gamma glutamyltransferase ultrasonography
项目摘要
Although the role of structural proteins in the epidermal mechanical barrier is clear, their role in the permeability barrier is unknown. We hypothesize that selected structural and enzymatic proteins; i.e., those that are both regulated by Ca++ and associated with the cornified envelope (CE): involucrin, loricrin, transglutaminase 1 (TG1), pro-fillaggrin, and K1/10, are regulated/required for barrier homeostasis. This proposal will assess which of these proteins are regulated by permeability barrier requirements, and how these CE-associated proteins, in partnership with the lipid bound envelope (LBE) and the lipid-enriched extracellular lamellae, from the permeability barrier. Specifically, in Aim #1 we will determine which CE- associated proteins are regulated by altered barrier requirements, and whether Ca++ regulates their expression, by: a) measuring the time course of mRNA/protein expression for the CE-associated proteins after acute barrier disruption (acetone, tape stripping) and in essential fatty acid deficiency (EFAD) in hairless mice. b) Ascertaining whether changes in extracellular Ca++ (in vivo by sonophoresis and by immersion) modulate expression of the regulated CE protein(s); and the participation of the calcium receptor (CaR) and voltage-sensitive Ca++ channels in these changes. c) Determining whether the transient decrease in CE-associated protein expression facilitates barrier recovery. Using three transgenic over- expressing (involucrin, K6/16, and pro-filaggrin) murine models, and one of these proteins interferes with permeability barrier homeostasis and lamellar body secretion. In Aim #2, we will determine which CE-associated proteins are required for normal barrier homeostasis, and the mechanisms by which alterations in these proteins lead to barrier abnormalities, by: a) Assessing homeostasis in human and murine models with specific deletions or mutations of CE-associated proteins; i.e., in patients with lamellar ichthyosis (LI; TG1 deletion), epidermolytic hyperkeratoses (EHK;K1 or 10 mutation), ichethyosis bullosa of Siemens (IBS; K2e mutation), palmo-plantar keratoderma (NSPPK; K1 mutation), ichthyosis, Keratoderma (NSPPK; K1 mutation), ichthyosis vulgaris (pro-filaggrin deficiency), Vohwinkle's disease (loricrin mutation), plus involucrin and K10 murine knockout animals. b) Assessing the mechanisms whereby CE-associated proteins influence permeability barrier function.
虽然结构蛋白在表皮机械屏障中的作用是明确的,但它们在渗透性屏障中的作用尚不清楚。我们假设,选择的结构和酶蛋白,即,那些既受Ca++调节又与皮层包膜(CE)相关的蛋白质:外皮蛋白、兜甲蛋白、转氨酶1(TG 1)、原丝蛋白和K1/10,是屏障稳态调节/所需的。该提案将评估这些蛋白质中哪些受渗透性屏障要求的调节,以及这些CE相关蛋白质如何与脂质结合包膜(LBE)和富含脂质的细胞外膜层合作,从渗透性屏障中分离。具体地,在目标#1中,我们将通过以下方式确定哪些CE相关蛋白受改变的屏障需求调节,以及Ca++是否调节它们的表达:a)在无毛小鼠中,在急性屏障破坏(丙酮、胶带剥离)后和必需脂肪酸缺乏(EFAD)中,测量CE相关蛋白的mRNA/蛋白表达的时间过程。B)确定细胞外Ca++的变化(在体内通过超声促渗和通过浸泡)是否调节调节的CE蛋白的表达;以及钙受体(CaR)和电压敏感性Ca++通道在这些变化中的参与。c)确定CE相关蛋白表达的瞬时降低是否促进屏障恢复。使用三种转基因过表达(外皮蛋白、K6/16和前聚丝蛋白)小鼠模型,这些蛋白质中的一种干扰渗透性屏障稳态和板层体分泌。 在目标#2中,我们将通过以下方式确定哪些CE相关蛋白是正常屏障稳态所需的,以及这些蛋白的改变导致屏障异常的机制:在患有板层状鱼鳞病(LI; TG 1缺失)、表皮炎性角化过度(EHK;K1或10突变)、Siemens大疱性鱼鳞病(IBS; K2 e突变)、掌跖角化病(NSPPK; K1突变)、鱼鳞病、角化病(NSPPK; K1突变)、寻常鱼鳞病(聚丝蛋白原缺乏)、Vohwinkle病(兜甲蛋白突变)以及外皮蛋白和K10鼠敲除动物的患者中。B)评估CE相关蛋白影响渗透性屏障功能的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter M Elias其他文献
Activators of Nuclear Hormone Receptors, PPARα and FXR, Accelerate Maturation of the Epidermal Permeability Barrier In Utero • 321
- DOI:
10.1203/00006450-199804001-00342 - 发表时间:
1998-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Mary L Williams;Karen Hanley;Yan Jiang;Debra Crumrine;Peter M Elias;Kenneth R Feingold - 通讯作者:
Kenneth R Feingold
Therapeutic Benefits of Natural Ingredients for Atopic Dermatitis
- DOI:
10.1007/s11655-017-2769-1 - 发表时间:
2017-09-01 - 期刊:
- 影响因子:2.500
- 作者:
George Man;Li-zhi Hu;Peter M Elias;Mao-qiang Man - 通讯作者:
Mao-qiang Man
GENDER EFFECTS ON THE MATURATION OF THE EPIDERMAL BARRIER TO WATER LOSS IN THE FETAL RAT. • 1268
性别对胎鼠表皮水丢失屏障成熟的影响。•1268
- DOI:
10.1203/00006450-199604001-01291 - 发表时间:
1996-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Karen Hanley;Ulrich Rassner;Lazlo Komüves;Peter M Elias;Kenneth R Feingold;Mary L Williams - 通讯作者:
Mary L Williams
Peter M Elias的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter M Elias', 18)}}的其他基金
Pathogenesis and Therapy of Ichthyosis in Disorders of Lipid Metabolism
脂质代谢紊乱引起的鱼鳞病的发病机制和治疗
- 批准号:
8232543 - 财政年份:2012
- 资助金额:
$ 19.83万 - 项目类别:
Pathogenesis and Therapy of Ichthyosis in Disorders of Lipid Metabolism
脂质代谢紊乱引起的鱼鳞病的发病机制和治疗
- 批准号:
9041538 - 财政年份:2012
- 资助金额:
$ 19.83万 - 项目类别:
Pathogenesis and Therapy of Ichthyosis in Disorders of Lipid Metabolism
脂质代谢紊乱引起的鱼鳞病的发病机制和治疗
- 批准号:
8434177 - 财政年份:2012
- 资助金额:
$ 19.83万 - 项目类别:
Regulation/Role of AcylCer in Normal Epidermis and Atopic Dermatitis
AcylCer 在正常表皮和特应性皮炎中的调节/作用
- 批准号:
8391561 - 财政年份:2010
- 资助金额:
$ 19.83万 - 项目类别:
Melanocyte-Keratinocyte Cross-Talk In Relation To Barrier Function
黑素细胞-角质形成细胞与屏障功能的交互作用
- 批准号:
8110569 - 财政年份:2010
- 资助金额:
$ 19.83万 - 项目类别:
Melanocyte-Keratinocyte Cross-Talk In Relation To Barrier Function
黑素细胞-角质形成细胞与屏障功能的交互作用
- 批准号:
8271286 - 财政年份:2010
- 资助金额:
$ 19.83万 - 项目类别:
Melanocyte-Keratinocyte Cross-Talk In Relation To Barrier Function
黑素细胞-角质形成细胞与屏障功能的交互作用
- 批准号:
7982510 - 财政年份:2010
- 资助金额:
$ 19.83万 - 项目类别:
Regulation/Role of AcylCer in Normal Epidermis and Atopic Dermatitis
AcylCer 在正常表皮和特应性皮炎中的调节/作用
- 批准号:
7931795 - 财政年份:2010
- 资助金额:
$ 19.83万 - 项目类别:
Regulation/Role of AcylCer in Normal Epidermis and Atopic Dermatitis
AcylCer 在正常表皮和特应性皮炎中的调节/作用
- 批准号:
8196327 - 财政年份:2010
- 资助金额:
$ 19.83万 - 项目类别:
Regulation/Role of AcylCer in Normal Epidermis and Atopic Dermatitis
AcylCer 在正常表皮和特应性皮炎中的调节/作用
- 批准号:
8597349 - 财政年份:2010
- 资助金额:
$ 19.83万 - 项目类别:
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
$ 19.83万 - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
$ 19.83万 - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
$ 19.83万 - 项目类别: